Literature DB >> 22926190

Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility.

Stacey B Dutton1, Christopher D Makinson1, Ligia A Papale1, Anupama Shankar1, Bindu Balakrishnan1, Kazu Nakazawa2, Andrew Escayg3.   

Abstract

Voltage-gated sodium channels (VGSCs) are essential for the generation and propagation of action potentials in electrically excitable cells. Dominant mutations in SCN1A, which encodes the Nav1.1 VGSC α-subunit, underlie several forms of epilepsy, including Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+). Electrophysiological analyses of DS and GEFS+ mouse models have led to the hypothesis that SCN1A mutations reduce the excitability of inhibitory cortical and hippocampal interneurons. To more directly examine the relative contribution of inhibitory interneurons and excitatory pyramidal cells to SCN1A-derived epilepsy, we first compared the expression of Nav1.1 in inhibitory parvalbumin (PV) interneurons and excitatory neurons from P22 mice using fluorescent immunohistochemistry. In the hippocampus and neocortex, 69% of Nav1.1 immunoreactive neurons were also positive for PV. In contrast, 13% and 5% of Nav1.1 positive cells in the hippocampus and neocortex, respectively, were found to co-localize with excitatory cells identified by CaMK2α immunoreactivity. Next, we reduced the expression of Scn1a in either a subset of interneurons (mainly PV interneurons) or excitatory cells by crossing mice heterozygous for a floxed Scn1a allele to either the Ppp1r2-Cre or EMX1-Cre transgenic lines, respectively. The inactivation of one Scn1a allele in interneurons of the neocortex and hippocampus was sufficient to reduce thresholds to flurothyl- and hyperthermia-induced seizures, whereas thresholds were unaltered following inactivation in excitatory cells. Reduced interneuron Scn1a expression also resulted in the generation of spontaneous seizures. These findings provide direct evidence for an important role of PV interneurons in the pathogenesis of Scn1a-derived epilepsies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy; Interneurons; Ion channels; Pyramidal neurons; SCN1A

Mesh:

Substances:

Year:  2012        PMID: 22926190      PMCID: PMC3740063          DOI: 10.1016/j.nbd.2012.08.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  41 in total

1.  Temporal binding at gamma frequencies in the brain: paving the way to epilepsy?

Authors:  A V Medvedev
Journal:  Australas Phys Eng Sci Med       Date:  2001-03       Impact factor: 1.430

2.  "Dormant basket cell" hypothesis revisited: relative vulnerabilities of dentate gyrus mossy cells and inhibitory interneurons after hippocampal status epilepticus in the rat.

Authors:  Robert S Sloviter; Colin A Zappone; Brian D Harvey; Argyle V Bumanglag; Roland A Bender; Michael Frotscher
Journal:  J Comp Neurol       Date:  2003-04-21       Impact factor: 3.215

3.  Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy.

Authors:  N C de Lanerolle; J H Kim; R J Robbins; D D Spencer
Journal:  Brain Res       Date:  1989-08-28       Impact factor: 3.252

4.  Epileptic fast activity can be explained by a model of impaired GABAergic dendritic inhibition.

Authors:  F Wendling; F Bartolomei; J J Bellanger; P Chauvel
Journal:  Eur J Neurosci       Date:  2002-05       Impact factor: 3.386

5.  Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures.

Authors:  B Schwaller; I V Tetko; P Tandon; D C Silveira; M Vreugdenhil; T Henzi; M-C Potier; M R Celio; A E P Villa
Journal:  Mol Cell Neurosci       Date:  2004-04       Impact factor: 4.314

6.  Very fast rhythmic activity on scalp EEG associated with epileptic spasms.

Authors:  Katsuhiro Kobayashi; Makio Oka; Tomoyuki Akiyama; Takushi Inoue; Kiyoko Abiru; Tatsuya Ogino; Harumi Yoshinaga; Yoko Ohtsuka; Eiji Oka
Journal:  Epilepsia       Date:  2004-05       Impact factor: 5.864

7.  Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study.

Authors:  Marquis P Vawter; Jeremy M Crook; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger; Kevin G Becker; William J Freed
Journal:  Schizophr Res       Date:  2002-11-01       Impact factor: 4.939

8.  Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.

Authors:  Tsung-Ung W Woo; John P Walsh; Francine M Benes
Journal:  Arch Gen Psychiatry       Date:  2004-07

9.  Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.

Authors:  Michael B Knable; Beata M Barci; Maree J Webster; James Meador-Woodruff; E Fuller Torrey
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

10.  Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage.

Authors:  Jessica A Gorski; Tiffany Talley; Mengsheng Qiu; Luis Puelles; John L R Rubenstein; Kevin R Jones
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  59 in total

Review 1.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

2.  Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.

Authors:  David A Dyment; Sarah C Schock; Kristen Deloughery; Minh Hieu Tran; Kerstin Ure; Lauryl M J Nutter; Amie Creighton; Julie Yuan; Umberto Banderali; Tanya Comas; Ewa Baumann; Anna Jezierski; Kym M Boycott; Alex E Mackenzie; Marzia Martina
Journal:  Genetics       Date:  2020-06-17       Impact factor: 4.562

3.  Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.

Authors:  Chao Tai; Yasuyuki Abe; Ruth E Westenbroek; Todd Scheuer; William A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

4.  Double trouble: impairment of two interneuron types in a dravet mouse model.

Authors:  Jennifer A Kearney
Journal:  Epilepsy Curr       Date:  2015 Jan-Feb       Impact factor: 7.500

5.  Disruption of Fgf13 causes synaptic excitatory-inhibitory imbalance and genetic epilepsy and febrile seizures plus.

Authors:  Ram S Puranam; Xiao Ping He; Lijun Yao; Tri Le; Wonjo Jang; Catherine W Rehder; Darrell V Lewis; James O McNamara
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

6.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

7.  Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome.

Authors:  Aliesha Griffin; Kyla R Hamling; Kelly Knupp; SoonGweon Hong; Luke P Lee; Scott C Baraban
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 8.  Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy.

Authors:  X Jiang; M Lachance; E Rossignol
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

9.  Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice.

Authors:  Ryan H Purcell; Ligia A Papale; Christopher D Makinson; Nikki T Sawyer; Jason P Schroeder; Andrew Escayg; David Weinshenker
Journal:  Psychopharmacology (Berl)       Date:  2013-03-14       Impact factor: 4.530

Review 10.  Pathophysiology of epileptic encephalopathies.

Authors:  Fred A Lado; Guido Rubboli; Giuseppe Capovilla; Pippo Capovilla; Giuliano Avanzini; Solomon L Moshé
Journal:  Epilepsia       Date:  2013-11       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.